Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Perceive Biotherapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Perceive Biotherapeutics

Perceive Biotherapeutics

Series B

Perceive Biotherapeutics: Pioneering novel ophthalmic biotech solutions.

HQ
South San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Perceive Biotherapeutics, founded with a mission to protect sight through unparalleled science and deep genetic insights, focuses on developing novel ophthalmic therapeutics. The company aims to translate protective biology into powerful therapies, particularly targeting retinal degeneration. Their market focus is on pioneering biotechnological solutions to address critical unmet needs in ophthalmology.

Notable affiliated individuals include K. Angela Macfarlane, JD as CEO, Anne Rubin, MBA as President, and Eugene De Juan, Jr., MD as Chief Strategy Officer. Key achievements involve assembling an experienced leadership team and advancing their pipeline of innovative treatments. Perceive Biotherapeutics has made a significant impact by leveraging deep genetic insights to develop transformative therapies in the field of ophthalmology.

Perceive Biotherapeutics - Similar Companies

Perfuse Therapeutics logo

Perfuse Therapeutics

Oculogenex logo

Oculogenex

oculogenex.com

Seeing Medicines logo

Seeing Medicines

EyeCyte logo

EyeCyte

eyecyte.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Imagen Biotech logo

Imagen Biotech

Drive Therapeutics logo

Drive Therapeutics

Qlaris Bio logo

Qlaris Bio

qlaris.bio

Therini Bio logo

Therini Bio

therinibio.com

Visiox logo

Visiox

visioxpharma.com

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

ReNetX Bio logo

ReNetX Bio

renetx.com

Character Biosciences logo

Character Biosciences

characterbio.com

Perceive Biotherapeutics - Quick Facts

Who are Perceive Biotherapeutics' competitors?

Companies similar to Perceive Biotherapeutics include Perfuse Therapeutics, Oculogenex, Seeing Medicines and EyeCyte.

When was Perceive Biotherapeutics founded?

Perceive Biotherapeutics was founded in 2020.

Where is Perceive Biotherapeutics' headquarters located?

Perceive Biotherapeutics' headquarters is located in South San Francisco, CA, US.

When was Perceive Biotherapeutics' last funding round?

Perceive Biotherapeutics' most recent funding round was for $78M (USD) in January 2023.

How much has Perceive Biotherapeutics raised to-date?

As of Jan 5, 2023, Perceive Biotherapeutics has raised a total of $78M (USD).

How many employees does Perceive Biotherapeutics have?

Perceive Biotherapeutics has 8 employees as of Feb 5, 2024.

Perceive Biotherapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified